Stanniocalcin-1 (STC1) is a secreted homodimeric glycoprotein hormone of the stanniocalcin family, originally characterized as a calcium-regulating hormone in fish and now known to function as a pleiotropic autocrine/paracrine regulator in mammals. STC1 stimulates renal phosphate reabsorption and inhibits calcium ion transport, contributing to mineral homeostasis. Recent work has identified STC1 as a potent inhibitor (Ki = 68 pM) of the metalloproteinase PAPP-A, thereby modulating IGF signaling through preventing cleavage of IGF-binding proteins. STC1 also functions as a selective modulator of HGF-induced angiogenic responses and inhibits transendothelial migration of inflammatory cells. The protein is widely expressed and is upregulated under hypoxia/stress conditions. In the heart, STC1 inhibits L-type calcium channels and may contribute to cardiac calcium homeostasis.
Definition: Inhibition of the proteolytic activity of pappalysin family metalloproteinases (PAPP-A and PAPP-A2). Stanniocalcins (STC1 and STC2) specifically inhibit these enzymes but not other metalloproteinases or serine proteinases.
Justification: STC1 and STC2 specifically inhibit the pappalysin family of metalloproteinases (PAPP-A and PAPP-A2) but not other metalloproteinases or serine proteinases [PMID:26195635]. A more specific term would be valuable for precise annotation.
Parent term: metalloendopeptidase inhibitor activity
Supporting Evidence:
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0006874
intracellular calcium ion homeostasis
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation inferred from phylogenetic analysis. STC1 was originally characterized as a calcium-regulating hormone in fish where it functions in preventing hypercalcemia [PMID:8700837]. Human STC1 has been shown to reversibly inhibit transmembrane calcium currents through L-channels in cardiomyocytes, slowing endogenous beating rate and diminishing intracellular calcium rise with each contraction [PMID:12663264]. The role in intracellular calcium homeostasis is well supported by experimental evidence across the stanniocalcin family.
Reason: This is a core conserved function of the stanniocalcin family. Multiple studies demonstrate STC1's role in calcium homeostasis - it inhibits calcium uptake in fish [PMID:8700837] and inhibits L-channel calcium currents in mammalian cardiomyocytes [PMID:12663264]. The IBA annotation appropriately captures this evolutionarily conserved function.
Supporting Evidence:
PMID:8700837
Recombinant hSTC inhibited the gill transport of calcium when administered to fish and stimulated renal phosphate reabsorption in the rat
PMID:12663264
Addition of recombinant STC1 to the medium of cultured rat cardiomyocytes slows their endogenous beating rate and diminishes the rise in intracellular calcium with each contraction
|
|
GO:0005615
extracellular space
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for cellular component. STC1 is a secreted glycoprotein hormone, consistent with its localization to the extracellular space. UniProt clearly indicates "Secreted" as the subcellular location, and the protein has a signal peptide (residues 1-17) [PMID:8700837, UniProt P52823].
Reason: STC1 is well-established as a secreted hormone. The protein has a signal peptide and is released to function in autocrine/paracrine signaling. This annotation is accurate and represents a core aspect of STC1 biology.
Supporting Evidence:
PMID:8700837
We have isolated a human cDNA clone encoding the mammalian homolog of stanniocalcin (STC), a calcium- and phosphate-regulating hormone that was first described in fishes where it functions in preventing hypercalcemia
PMID:14500721
Stanniocalcin 1 (STC1) is a secreted glycoprotein originally described as a hormone involved in calcium and phosphate homeostasis in bony fishes
|
|
GO:0007165
signal transduction
|
IEA
GO_REF:0000108 |
ACCEPT |
Summary: IEA annotation based on logical inference. STC1 functions as a signaling molecule that modulates multiple pathways including HGF/c-met signaling [PMID:14500721] and has been shown to bind Notch1 to activate Notch signaling in cancer contexts [deep research]. However, "signal transduction" is a very broad term.
Reason: While broad, this annotation is accurate. STC1 is a secreted hormone that acts via autocrine/paracrine mechanisms to regulate cellular responses. It modulates HGF-induced signaling and affects downstream pathways like focal adhesion kinase. As an IEA annotation, the breadth is acceptable given the well-documented signaling roles of STC1.
Supporting Evidence:
PMID:14500721
STC1 did not inhibit HGF-induced c-met receptor phosphorylation, but did block HGF-induced focal adhesion kinase activation
|
|
GO:0005179
hormone activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for molecular function. STC1 is classified as a hormone in UniProt and was originally identified as the mammalian homolog of fish stanniocalcin, a calcium-regulating hormone. STC1 acts via autocrine/paracrine mechanisms to regulate mineral homeostasis and cellular responses [PMID:8700837].
Reason: This accurately captures STC1's function as a hormone. The stanniocalcin family was originally characterized as hormonal regulators of mineral metabolism. STC1 is secreted and acts on target cells to modulate calcium/phosphate handling and other cellular processes.
Supporting Evidence:
PMID:8700837
Human stanniocalcin: a possible hormonal regulator of mineral metabolism
|
|
GO:0005576
extracellular region
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for cellular component. This is a broader parent term of "extracellular space" (GO:0005615) which is already annotated with IBA evidence. Both are correct - STC1 is a secreted protein that localizes to the extracellular region.
Reason: Accurate annotation. STC1 is a secreted glycoprotein and localizes to the extracellular region. This IEA annotation is consistent with the more specific IBA annotation for extracellular space.
Supporting Evidence:
PMID:8700837
Human STC (hSTC) was found to be 247 amino acids long
|
|
GO:0001503
ossification
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation transferred from orthologs. STC1 has been shown to regulate growth plate chondrogenesis and bone development in studies using recombinant human STC1 [PMID:16377640]. The annotation is supported by evidence that STC1 overexpression causes dwarfism in mice.
Reason: While STC1 does affect bone development and the annotation is accurate based on experimental studies, ossification is not a core function of STC1. The primary functions are mineral homeostasis, PAPP-A inhibition, and angiogenesis regulation. Bone effects may be secondary to its role in phosphate handling and IGF signaling modulation.
Supporting Evidence:
PMID:16377640
STC1 inhibits longitudinal bone growth directly at the growth plate
|
|
GO:0005615
extracellular space
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation transferred from orthologs for cellular component. Duplicate of the IBA annotation above. STC1 is clearly a secreted protein localized to the extracellular space.
Reason: Accurate annotation supported by multiple lines of evidence. Having both IBA and IEA evidence for the same term is acceptable and reflects consistent annotation across species and methods.
Supporting Evidence:
PMID:14500721
Stanniocalcin 1 (STC1) is a secreted glycoprotein
|
|
GO:0007566
embryo implantation
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation transferred from orthologs. STC1 expression has been associated with reproductive processes and decidualization, which relates to embryo implantation. However, direct experimental evidence for STC1's role in embryo implantation is limited.
Reason: This annotation may reflect expression data or ortholog-based inference rather than direct functional evidence. STC1's pleiotropic nature means it is expressed in many tissues including reproductive organs, but embryo implantation is not considered a primary function based on available literature.
Supporting Evidence:
file:human/STC1/STC1-deep-research-falcon.md
STC1 is expressed in reproductive organs
|
|
GO:0016324
apical plasma membrane
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation transferred from orthologs. STC1 has been detected on the apical surface of endothelial cells in vivo [PMID:17032941]. The annotation is consistent with STC1's role in regulating transendothelial migration.
Reason: Supported by direct detection of STC1 on the apical surface of endothelial cells. This localization is relevant to STC1's function in modulating inflammatory cell transmigration and endothelial function.
Supporting Evidence:
PMID:17032941
STC1 regulates gene expression in cultured endothelial cells and is detected on the apical surface of endothelial cells in vivo
|
|
GO:0033280
response to vitamin D
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation transferred from orthologs. STC1 is involved in mineral homeostasis and vitamin D is a key regulator of calcium metabolism. The connection is plausible given STC1's role in calcium/phosphate handling, but direct evidence from the publications reviewed is limited.
Reason: While the connection between STC1 and vitamin D signaling is biologically plausible given their shared roles in mineral metabolism, this is not a core function based on available direct experimental evidence. The annotation may reflect expression regulation rather than direct functional involvement.
Supporting Evidence:
PMID:8700837
The evidence suggests that mammalian STC, like its piscine counterpart, is a regulator of mineral homeostasis
|
|
GO:0046697
decidualization
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation transferred from orthologs. STC1 is expressed in reproductive tissues and may have roles in uterine biology. However, direct evidence for STC1 function in decidualization from the primary literature reviewed is limited.
Reason: This annotation likely reflects expression patterns in uterine tissue rather than direct functional evidence. Decidualization is not a primary function of STC1 based on the core literature, though expression in reproductive organs is documented.
Supporting Evidence:
file:human/STC1/STC1-deep-research-falcon.md
STC1 is expressed in reproductive organs
|
|
GO:0071320
cellular response to cAMP
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation transferred from orthologs. STC1 expression may be regulated by cAMP signaling, but direct evidence for functional involvement in cellular response to cAMP is limited in the literature reviewed.
Reason: This annotation likely reflects transcriptional regulation of STC1 by cAMP rather than STC1 being a mediator of cAMP responses. Not a core function based on available evidence.
Supporting Evidence:
file:human/STC1/STC1-deep-research-falcon.md
STC1 is induced by stress/hypoxia pathways
|
|
GO:0071385
cellular response to glucocorticoid stimulus
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: IEA annotation transferred from orthologs. STC1 expression may be regulated by glucocorticoids, but this reflects transcriptional regulation rather than STC1 being a core mediator of glucocorticoid responses.
Reason: This annotation likely reflects STC1 being a glucocorticoid-responsive gene rather than a primary mediator of glucocorticoid responses. Not a core function of STC1.
Supporting Evidence:
file:human/STC1/STC1-deep-research-falcon.md
STC1 is widely expressed in many organs
|
|
GO:0071456
cellular response to hypoxia
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: IEA annotation transferred from orthologs. STC1 is known to be induced by hypoxia and stress pathways. The deep research indicates STC1 is linked to hypoxia-driven programs and functions in stress responses [deep research]. STC1 upregulation in failing hearts is relevant to hypoxic stress [PMID:12663264].
Reason: This annotation is well-supported. STC1 is induced by hypoxia/stress and may play protective roles under hypoxic conditions. The protein is markedly upregulated in failing hearts (a hypoxic condition) and is reduced after mechanical unloading [PMID:12663264]. Hypoxia regulation is a documented aspect of STC1 biology.
Supporting Evidence:
PMID:12663264
STC1 protein is markedly upregulated in cardiomyocytes and arterial walls of failing hearts pre-LVAD and is strikingly reduced after LVAD treatment
file:human/STC1/STC1-deep-research-falcon.md
STC1 is linked to hypoxia-driven programs and stress responses
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MODIFY |
Summary: IPI annotation based on high-throughput interactome study (HuRI). The study identified STC1 interacting with MEOX2. However, "protein binding" is uninformative - it does not specify the functional nature of the interaction.
Reason: "Protein binding" is too vague and uninformative. STC1 has specific and functionally important protein interactions - most notably it binds and inhibits PAPP-A with very high affinity (KD = 75 pM) [PMID:26195635]. It also forms homodimers. The annotation should be replaced with more specific molecular function terms.
Proposed replacements:
metalloendopeptidase inhibitor activity
Supporting Evidence:
PMID:32296183
Global insights into cellular organization and genome function require comprehensive understanding of the interactome networks
|
|
GO:0042802
identical protein binding
|
IPI
PMID:26195635 Stanniocalcin-1 Potently Inhibits the Proteolytic Activity o... |
ACCEPT |
Summary: IPI annotation from PMID:26195635 which demonstrated STC1 homodimerization. The paper states that STC1 is a "disulfide-bound homodimeric glycoprotein." UniProt also confirms "Homodimer; disulfide-linked." IntAct records STC1-STC1 interaction.
Reason: This annotation is well-supported by the primary literature. STC1 functions as a homodimer linked by disulfide bonds. This is a core structural feature of the protein.
Supporting Evidence:
PMID:26195635
Stanniocalcin-1 (STC1) is a disulfide-bound homodimeric glycoprotein
|
|
GO:0030336
negative regulation of cell migration
|
IDA
PMID:17032941 Stanniocalcin-1 regulates endothelial gene expression and mo... |
ACCEPT |
Summary: IDA annotation based on direct experimental evidence. The study showed that STC1 inhibits transmigration of macrophages and T lymphocytes through endothelial cell monolayers [PMID:17032941]. STC1 also inhibits chemotaxis of macrophage-like cells.
Reason: Well-supported by direct experimental evidence. STC1 inhibits the migration of specific immune cell types (macrophages, T lymphocytes) across endothelial barriers. This is a core functional role consistent with STC1's autocrine/paracrine signaling function.
Supporting Evidence:
PMID:17032941
STC1 inhibited transmigration of macrophages and T lymphocytes through quiescent or IL-1beta-activated HUVECs but did not attenuate the transmigration of neutrophils and B lymphocytes
|
|
GO:0006874
intracellular calcium ion homeostasis
|
IDA
PMID:8700837 Human stanniocalcin: a possible hormonal regulator of minera... |
ACCEPT |
Summary: IDA annotation from the foundational paper characterizing human STC1. The study showed that recombinant hSTC inhibited calcium transport in fish gills and stimulated renal phosphate reabsorption in rats, indicating a role in mineral metabolism and calcium homeostasis [PMID:8700837].
Reason: This is the core conserved function of stanniocalcins - regulation of calcium homeostasis. The original identification of human STC1 demonstrated its ability to inhibit calcium transport, consistent with fish STC function. This is fundamental to STC1 biology.
Supporting Evidence:
PMID:8700837
Recombinant hSTC inhibited the gill transport of calcium when administered to fish and stimulated renal phosphate reabsorption in the rat
|
|
GO:0051926
negative regulation of calcium ion transport
|
IDA
PMID:8700837 Human stanniocalcin: a possible hormonal regulator of minera... |
ACCEPT |
Summary: IDA annotation from the foundational paper. STC1 inhibits calcium transport - demonstrated by recombinant hSTC inhibiting gill calcium transport in fish [PMID:8700837]. Further supported by patch-clamp studies showing STC1 inhibits L-channel calcium currents in cardiomyocytes [PMID:12663264].
Reason: Well-supported core function. STC1 negatively regulates calcium transport across multiple experimental systems and cell types. This is the primary molecular activity underlying STC1's role in calcium homeostasis.
Supporting Evidence:
PMID:8700837
Recombinant hSTC inhibited the gill transport of calcium when administered to fish and stimulated renal phosphate reabsorption in the rat
PMID:12663264
using whole cell patch-clamp studies in cultured rat cardiomyocytes, we find that addition of STC1 to the bath causes reversible inhibition of transmembrane calcium currents through L-channels
|
|
GO:1903403
negative regulation of renal phosphate excretion
|
IDA
PMID:8700837 Human stanniocalcin: a possible hormonal regulator of minera... |
ACCEPT |
Summary: IDA annotation from the foundational paper. The study demonstrated that recombinant hSTC "stimulated renal phosphate reabsorption in the rat" [PMID:8700837]. Stimulating reabsorption is equivalent to negatively regulating excretion.
Reason: Well-supported core function. STC1 stimulates renal phosphate reabsorption, thereby reducing phosphate excretion. This is part of STC1's fundamental role as a regulator of mineral homeostasis, specifically phosphate handling in the kidney.
Supporting Evidence:
PMID:8700837
Recombinant hSTC inhibited the gill transport of calcium when administered to fish and stimulated renal phosphate reabsorption in the rat
|
|
GO:0001886
endothelial cell morphogenesis
|
IDA
PMID:14500721 Stanniocalcin 1 is an autocrine modulator of endothelial ang... |
ACCEPT |
Summary: IDA annotation from the angiogenesis study. The paper showed that STC1 is "a selective modulator of hepatocyte growth factor (HGF)-induced endothelial migration and morphogenesis" [PMID:14500721]. STC1 acts as a "stop signal" or stabilizing factor for blood vessel maturation.
Reason: Supported by direct experimental evidence showing STC1 modulates HGF-induced endothelial morphogenesis. This is a well-characterized function where STC1 acts to regulate the maturation and morphogenesis of endothelial cells during angiogenesis.
Supporting Evidence:
PMID:14500721
STC1 is a selective modulator of hepatocyte growth factor (HGF)-induced endothelial migration and morphogenesis, but not proliferation
|
|
GO:0003421
growth plate cartilage axis specification
|
IDA
PMID:16377640 Stanniocalcin 1 acts as a paracrine regulator of growth plat... |
KEEP AS NON CORE |
Summary: IDA annotation from the chondrogenesis study. The paper demonstrated that STC1 acts as a "paracrine regulator of growth plate chondrogenesis" affecting growth plate chondrocyte proliferation and differentiation [PMID:16377640].
Reason: While the annotation is supported by experimental evidence, "growth plate cartilage axis specification" is a very specific developmental term. The study primarily showed effects on chondrocyte proliferation and differentiation, which may be secondary to STC1's effects on phosphate transport. This is not a primary molecular function.
Supporting Evidence:
PMID:16377640
STC1 inhibits longitudinal bone growth directly at the growth plate
|
|
GO:0035988
chondrocyte proliferation
|
IDA
PMID:16377640 Stanniocalcin 1 acts as a paracrine regulator of growth plat... |
KEEP AS NON CORE |
Summary: IDA annotation from the chondrogenesis study. The paper directly showed that rhSTC "suppressed metatarsal growth, growth plate chondrocyte proliferation and hypertrophy/differentiation" [PMID:16377640].
Reason: Supported by direct experimental evidence but represents a tissue-specific effect rather than core function. The effects on chondrocyte proliferation appear to be mediated through phosphate transport modulation rather than direct regulation of proliferation pathways.
Supporting Evidence:
PMID:16377640
rhSTC suppressed metatarsal growth, growth plate chondrocyte proliferation and hypertrophy/differentiation
|
|
GO:0044070
regulation of monoatomic anion transport
|
IDA
PMID:16377640 Stanniocalcin 1 acts as a paracrine regulator of growth plat... |
ACCEPT |
Summary: IDA annotation from the chondrogenesis study. The paper showed that rhSTC "increased phosphate uptake" in chondrocytes and that the effects were reversed by phosphonoformic acid, an inhibitor of phosphate transport [PMID:16377640].
Reason: Well-supported annotation consistent with STC1's core function in mineral ion transport. The study directly demonstrated that STC1 regulates phosphate (a monoatomic anion) transport in chondrocytes, mechanistically linking to effects on bone development.
Supporting Evidence:
PMID:16377640
In cultured chondrocytes, rhSTC increased phosphate uptake... All these effects were reversed by culturing chondrocytes with rhSTC and phosphonoformic acid, an inhibitor of phosphate transport
|
|
GO:0060348
bone development
|
IDA
PMID:16377640 Stanniocalcin 1 acts as a paracrine regulator of growth plat... |
KEEP AS NON CORE |
Summary: IDA annotation from the chondrogenesis study. The paper demonstrated STC1's role in regulating longitudinal bone growth through effects on growth plate chondrogenesis. STC1 overexpression in mice causes dwarfism [PMID:16377640].
Reason: While supported by experimental evidence, bone development effects are likely secondary to STC1's primary role in regulating phosphate transport and possibly IGF signaling (via PAPP-A inhibition). Not a core molecular function of STC1.
Supporting Evidence:
PMID:16377640
STC1 inhibits longitudinal bone growth directly at the growth plate. Such growth inhibition, likely mediated by an increased chondrocyte phosphate uptake
|
|
GO:0090280
positive regulation of calcium ion import
|
IDA
PMID:17032941 Stanniocalcin-1 regulates endothelial gene expression and mo... |
REMOVE |
Summary: IDA annotation from PMID:17032941. However, this annotation appears inconsistent with the major body of evidence showing STC1 INHIBITS calcium transport. The paper focuses on endothelial function and inflammatory cell migration, and the abstract states STC1 "may involve attenuation of the intracellular calcium signal."
Reason: This annotation appears to be erroneous. The overwhelming evidence shows STC1 INHIBITS calcium transport and reduces intracellular calcium levels [PMID:8700837, PMID:12663264]. PMID:17032941 actually states STC1 attenuates intracellular calcium signals in chemotaxis. The annotation should be removed as it contradicts the established biology of STC1.
Supporting Evidence:
PMID:17032941
The mammalian counterpart of the fish calcium-regulating hormone stanniocalcin-1 (STC1) inhibits monocyte chemotactic protein-1- and stromal-derived factor-1alpha (SDF-1alpha)-mediated chemotaxis and diminishes chemokinesis in macrophage-like RAW264.7 and U937 cells in a manner that may involve attenuation of the intracellular calcium signal
|
|
GO:0005634
nucleus
|
IDA
PMID:12663264 Stanniocalcin-1 is a naturally occurring L-channel inhibitor... |
ACCEPT |
Summary: IDA annotation from the cardiomyocyte study. The paper states "STC1 is diffusely expressed in cardiomyocytes, although nuclear predominance is apparent" [PMID:12663264]. Nuclear localization of a secreted protein is unusual but was observed in this study.
Reason: Supported by direct immunolocalization studies in cardiomyocytes showing nuclear predominance. While STC1 is primarily a secreted protein, some intracellular localization has been documented, possibly related to internalization mechanisms.
Supporting Evidence:
PMID:12663264
STC1 is diffusely expressed in cardiomyocytes, although nuclear predominance is apparent
|
|
GO:0005737
cytoplasm
|
IDA
PMID:12663264 Stanniocalcin-1 is a naturally occurring L-channel inhibitor... |
ACCEPT |
Summary: IDA annotation from the cardiomyocyte study. The paper states "STC1 is diffusely expressed in cardiomyocytes" indicating cytoplasmic localization [PMID:12663264]. As a secreted protein, STC1 transits through the cytoplasm during biosynthesis.
Reason: Supported by immunolocalization studies. STC1 was detected diffusely in cardiomyocytes, consistent with cytoplasmic presence during secretory pathway transit or after internalization.
Supporting Evidence:
PMID:12663264
STC1 is diffusely expressed in cardiomyocytes
|
|
GO:0006874
intracellular calcium ion homeostasis
|
IDA
PMID:12663264 Stanniocalcin-1 is a naturally occurring L-channel inhibitor... |
ACCEPT |
Summary: IDA annotation from the cardiomyocyte study. The paper directly demonstrated that STC1 affects intracellular calcium in cardiomyocytes by inhibiting L-channel calcium currents and reducing intracellular calcium rise with each contraction [PMID:12663264].
Reason: Strong experimental evidence showing STC1 regulates intracellular calcium homeostasis in cardiomyocytes. This complements the IBA and earlier IDA annotations for the same term and represents a core function of STC1.
Supporting Evidence:
PMID:12663264
Addition of recombinant STC1 to the medium of cultured rat cardiomyocytes slows their endogenous beating rate and diminishes the rise in intracellular calcium with each contraction
|
|
GO:0010596
negative regulation of endothelial cell migration
|
IDA
PMID:14500721 Stanniocalcin 1 is an autocrine modulator of endothelial ang... |
ACCEPT |
Summary: IDA annotation from the angiogenesis study. The paper showed that "STC1 is a selective modulator of hepatocyte growth factor (HGF)-induced endothelial migration" - specifically it inhibits HGF-induced migration [PMID:14500721].
Reason: Well-supported by direct experimental evidence. STC1 selectively inhibits HGF-induced endothelial cell migration (but not VEGF or bFGF-induced migration). This is a key function in STC1's role as an autocrine modulator of angiogenesis.
Supporting Evidence:
PMID:14500721
STC1 is a selective modulator of hepatocyte growth factor (HGF)-induced endothelial migration and morphogenesis, but not proliferation. STC1 did not inhibit proliferative or migratory responses to vascular endothelial growth factor or basic fibroblast growth factor.
|
|
GO:0086004
regulation of cardiac muscle cell contraction
|
IDA
PMID:12663264 Stanniocalcin-1 is a naturally occurring L-channel inhibitor... |
ACCEPT |
Summary: IDA annotation from the cardiomyocyte study. The paper demonstrated that STC1 "slows their endogenous beating rate" in cultured cardiomyocytes through L-channel inhibition [PMID:12663264].
Reason: Supported by direct functional evidence showing STC1 regulates cardiomyocyte contractility by inhibiting calcium currents and slowing beating rate. This may be relevant to cardiac pathophysiology in heart failure.
Supporting Evidence:
PMID:12663264
Addition of recombinant STC1 to the medium of cultured rat cardiomyocytes slows their endogenous beating rate
|
|
GO:0008191
metalloendopeptidase inhibitor activity
|
IDA
PMID:26195635 Stanniocalcin-1 Potently Inhibits the Proteolytic Activity o... |
NEW |
Summary: New annotation based on PMID:26195635 which demonstrated that STC1 is a potent inhibitor of the metalloproteinase PAPP-A. STC1 binds PAPP-A with very high affinity (KD = 75 pM) and inhibits its proteolytic activity (Ki = 68 pM). This inhibition affects IGF signaling by preventing IGFBP cleavage.
Reason: This represents a newly recognized and important molecular function of STC1 that should be annotated. STC1 is a proteinase inhibitor specific for the pappalysin family of metalloproteinases. This function links STC1 to IGF signaling regulation and may explain some of its growth-related effects.
Supporting Evidence:
PMID:26195635
We here demonstrate that STC1 is an inhibitor of the metzincin metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A)... STC1 potently (Ki = 68 pm) inhibits PAPP-A cleavage of IGFBP-4
|
Q: What is the receptor for STC1 in mammalian tissues beyond Notch1? While Notch1 has been identified as a receptor in cancer contexts, the broader receptor landscape for STC1 remains incompletely defined. Understanding the receptor(s) would clarify the signaling mechanism.
Q: Does the PAPP-A inhibitory function of STC1 contribute to its effects on bone growth? STC1 overexpression causes dwarfism, and STC1 inhibits PAPP-A which regulates IGF signaling. It is unclear if growth effects are primarily through phosphate transport or IGF axis modulation.
Experiment: Test whether STC1 effects on chondrocyte proliferation are blocked by PAPP-A overexpression to determine if PAPP-A inhibition contributes to growth plate effects. If PAPP-A inhibition is the mechanism, excess PAPP-A should rescue STC1-mediated growth suppression.
Hypothesis: PAPP-A inhibition contributes to STC1-mediated growth suppression in chondrocytes
Experiment: Identify the primary receptor for STC1 in endothelial cells using crosslinking and mass spectrometry approaches to identify endothelial cell surface receptor(s) mediating STC1 effects on HGF signaling and migration.
Hypothesis: STC1 has a specific cell surface receptor in endothelial cells distinct from Notch1
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan and identity verification
- Target verified: STC1 (stanniocalcin-1) is a human secreted glycoprotein hormone of the stanniocalcin family, encoded on chromosome 8p11.2–p21, ubiquitously expressed, and functioning largely via autocrine/paracrine mechanisms; these features align with UniProt P52823 and stanniocalcin family/domain annotations (reviewed in 2024) (wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3).
1) Key concepts and definitions
- Molecular class and structure: STC1 is a dimeric, heavily glycosylated secreted phosphoprotein of the stanniocalcin family. Human STC1 contains multiple conserved cysteines and is secreted to the extracellular milieu; it can bind a membrane protein, be internalized, and localize to the inner mitochondrial membrane (Frontiers in Immunology, 2024; doi:10.3389/fimmu.2024.1510182) (wang2024stanniocalcin1intumor pages 2-3).
- Localization and secretion: STC1 is secreted from human cells (e.g., fibrosarcoma) and detected broadly in human tissues (brain, thymus, spleen, parathyroid, lung, heart, skeletal muscle, kidney, pancreas, gut, placenta, reproductive organs) (Frontiers in Immunology, 2024; https://doi.org/10.3389/fimmu.2024.1510182) (wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3).
- Core biology: Originally described for mineral handling, STC1 is now established as a pleiotropic cytokine-like hormone modulating cell survival, stress responses, and immune interactions in the tumor microenvironment (TME), including macrophage differentiation/activation and phagocytosis checkpoints (Frontiers in Immunology, 2024; https://doi.org/10.3389/fimmu.2024.1510182) (wang2024stanniocalcin1intumor pages 10-10, wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3).
2) Recent developments and latest research (2023–2024)
- Notch1 as a direct receptor/partner: Cancer-associated fibroblast (CAF)-derived STC1 directly binds Notch1 on hepatocellular carcinoma (HCC) cells, activating Notch signaling to promote cancer stemness. Co-immunoprecipitation and colocalization in human HCC models demonstrate a physical STC1–Notch1 interaction; a feedforward loop exists in which NICD/CSL directly upregulates STC1 via the promoter, correlating with poor prognosis in patient samples (Journal of Translational Medicine, 2023; https://doi.org/10.1186/s12967-023-04085-8) (bai2023thestromaltumoramplifying pages 7-12).
- Hypoxia and stress-associated induction: Across cancers, STC1 is linked to hypoxia-driven programs and stress responses; a 2024 review synthesizes the role of STC1 in TME remodeling and immune evasion, summarizing hypoxia-inducible regulation and macrophage-centric effects (Frontiers in Immunology, 2024; https://doi.org/10.3389/fimmu.2024.1510182) (wang2024stanniocalcin1intumor pages 10-10, wang2024stanniocalcin1intumor pages 2-3).
- Phagocytosis checkpoint activity: STC1 functions as a phagocytosis checkpoint in tumors, modulating macrophage phagocytic balance and contributing to immune escape within the TME; multiple lines of experimental evidence in human tumors support this paradigm (reviewed 2024) (Frontiers in Immunology, 2024; https://doi.org/10.3389/fimmu.2024.1510182) (wang2024stanniocalcin1intumor pages 10-10, wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3).
- Chemoresistance mechanisms in glioblastoma (GBM): In 2024, STC1 was shown to drive temozolomide (TMZ) resistance in GBM by increasing STAT3 phosphorylation (Tyr705), upregulating MGMT, and reducing TMZ-induced DNA damage and apoptosis; STC1 knockdown enhances TMZ sensitivity in vitro and in xenografts (Scientific Reports, 2024; https://doi.org/10.1038/s41598-024-68902-w) (duan2024stanniocalcin1promotestemozolomide pages 8-10).
- Colorectal cancer (CRC) proliferation/metastasis and immune evasion: An Oct 2024 integrative analysis identified STC1 as a critical component of a recurrence-related gene signature; experimental validation showed that STC1 knockdown reduces proliferation and metastasis in vitro and in vivo, and mechanistically supports PD-L1–mediated immune escape (Journal of Cancer, 2024; https://doi.org/10.7150/jca.102605) (xu2024integrativeanalysisof pages 12-14).
- miRNA regulation in TNBC: miR‑606 targets STC1 and suppresses TNBC growth and metastasis in vitro and in xenografts; patient data showed opposing survival associations for miR‑606 and STC1 expression (Oncology Reports, 2023; https://doi.org/10.3892/or.2023.8661) (choi2023microrna‑606inhibitsthe pages 11-11).
3) Current applications and real-world implementations
- Biomarkers and prognosis:
• Meta-analysis across 16 studies (n=2,942) found high STC1 predicts worse prognosis, with pronounced effects in digestive cancers (HR 1.73; 95% CI 1.36–2.20) and nervous system tumors (HR 2.60; 95% CI 1.29–2.25) (Frontiers in Immunology, 2024; synthesis of published cohorts) (wang2024stanniocalcin1intumor pages 2-3).
• CRC risk-stratification and recurrence modeling: Inclusion of STC1 in an 11-gene recurrence-related signature improved prognostic and therapy response prediction across multiple CRC datasets; functionally, STC1 promoted proliferation/metastasis and immune evasion, highlighting translational utility (Journal of Cancer, 2024; https://doi.org/10.7150/jca.102605) (xu2024integrativeanalysisof pages 12-14).
• GBM therapy resistance: STC1 expression correlated with TMZ resistance and adverse outcome; targeting STC1/STAT3–MGMT signaling is a candidate strategy to reverse chemoresistance (Scientific Reports, 2024; https://doi.org/10.1038/s41598-024-68902-w) (duan2024stanniocalcin1promotestemozolomide pages 8-10).
- TME-targeted strategies: The STC1–Notch1 feedforward loop in HCC underscores a druggable stromal–tumor axis; genetic or pharmacologic Notch blockade (e.g., γ-secretase inhibitor RO4929097) attenuated STC1-driven stemness in model systems (Journal of Translational Medicine, 2023; https://doi.org/10.1186/s12967-023-04085-8) (bai2023thestromaltumoramplifying pages 7-12).
4) Expert opinions and analysis from authoritative sources
- Comprehensive immune-oncology perspective: A 2024 Frontiers in Immunology review consolidates evidence that STC1 is an emerging phagocytosis checkpoint acting via macrophages, integrates mechanistic reports (e.g., secretion, mitochondrial targeting, pathway crosstalk), and interprets multi-cohort clinical data linking high STC1 to poor outcomes in several cancers (https://doi.org/10.3389/fimmu.2024.1510182) (wang2024stanniocalcin1intumor pages 10-10, wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3).
- Mechanistic consensus points drawn from recent primary studies:
• Direct receptor engagement: STC1 directly binds Notch1 on human cancer cells, establishing a signaling feedforward loop (J Transl Med, 2023) (bai2023thestromaltumoramplifying pages 7-12).
• Therapy resistance signaling: STC1 drives STAT3–MGMT chemoresistance in GBM (Sci Rep, 2024) (duan2024stanniocalcin1promotestemozolomide pages 8-10).
• Immune escape: In CRC and other tumors, STC1 supports immune evasion, including PD-L1 upregulation and macrophage-linked suppression of phagocytosis (Journal of Cancer, 2024; review 2024) (xu2024integrativeanalysisof pages 12-14, wang2024stanniocalcin1intumor pages 2-3).
5) Relevant statistics and data (recent)
- Prognostic meta-analysis: High STC1 associated with worse overall survival—digestive cancers HR 1.73 (95% CI 1.36–2.20), nervous system tumors HR 2.60 (95% CI 1.29–2.25) (Frontiers in Immunology, 2024; meta-analysis summarized) (wang2024stanniocalcin1intumor pages 2-3).
- CRC functional and prognostic data: STC1 knockdown reduced proliferation and metastasis; the STC1-containing 11-gene signature predicted overall and disease-free survival, with higher scores correlating with stage and poor outcomes across validation cohorts (Journal of Cancer, 2024; https://doi.org/10.7150/jca.102605) (xu2024integrativeanalysisof pages 12-14).
- GBM chemoresistance: STC1 overexpression increased p‑STAT3 and MGMT, decreased TMZ-induced DNA damage; STC1 depletion enhanced TMZ response in vitro and in intracranial models (Scientific Reports, 2024; https://doi.org/10.1038/s41598-024-68902-w) (duan2024stanniocalcin1promotestemozolomide pages 8-10).
Pathways and mechanisms (concise mechanistic map)
- Mineral handling and endocrine crosstalk: Although human STC1’s systemic mineral regulatory role remains less defined than in fish, its secreted, glycoprotein hormone nature and tissue distribution match conserved stanniocalcin biology (review 2024) (wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3).
- Notch signaling: Direct STC1 binding to Notch1 activates Notch target programs and reinforces STC1 transcription through CSL binding, supporting stemness and therapy resistance in HCC (J Transl Med, 2023; https://doi.org/10.1186/s12967-023-04085-8) (bai2023thestromaltumoramplifying pages 7-12).
- Stress, hypoxia, and immune regulation: STC1 is upregulated by hypoxia/stress pathways and operates in the TME to modulate macrophage activation and phagocytic checkpoints, contributing to immune escape (Frontiers in Immunology, 2024; https://doi.org/10.3389/fimmu.2024.1510182) (wang2024stanniocalcin1intumor pages 10-10, wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3).
- DNA repair/chemoresistance axis in GBM: STC1 augments STAT3 activity, elevates MGMT, and blunts alkylator-induced DNA damage (Scientific Reports, 2024; https://doi.org/10.1038/s41598-024-68902-w) (duan2024stanniocalcin1promotestemozolomide pages 8-10).
- PD-L1 and immune evasion in CRC: STC1 contributes to PD-L1 upregulation and pro-metastatic programs, linking tumor-intrinsic signaling to immune suppression (Journal of Cancer, 2024; https://doi.org/10.7150/jca.102605) (xu2024integrativeanalysisof pages 12-14).
Research gaps and cautions
- Receptor landscape: Beyond the validated STC1–Notch1 binding in HCC, the broader receptor(s) for STC1 in human tissues remain incompletely defined; multiple reports suggest cell-surface binding with internalization and mitochondrial targeting, but high-affinity receptors outside Notch1 are still under active investigation (Frontiers in Immunology, 2024; https://doi.org/10.3389/fimmu.2024.1510182; J Transl Med, 2023) (wang2024stanniocalcin1intumor pages 2-3, bai2023thestromaltumoramplifying pages 7-12).
- Canonical endocrine functions in humans: STC1’s systemic roles in calcium/phosphate homeostasis in humans are not yet as mechanistically established as in fish; current evidence emphasizes local autocrine/paracrine actions in stress response and tumor biology (review 2024) (wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3).
Summary
Human STC1 (UniProt P52823) is a secreted, glycosylated stanniocalcin-family hormone with widespread expression and autocrine/paracrine actions. Recent work clarifies that STC1 directly binds Notch1 to drive stemness in HCC, acts as an immune phagocytosis checkpoint through macrophage-centered TME remodeling, and confers chemoresistance in GBM via STAT3–MGMT activation. Clinically, high STC1 is repeatedly associated with worse outcomes across cancers, with recent 2023–2024 studies providing mechanistic depth and prognostic/therapeutic implications. Together, these advances position STC1 as a promising biomarker and candidate target in oncology, while its full receptor repertoire and systemic endocrine roles in humans remain active areas of research (wang2024stanniocalcin1intumor pages 1-2, wang2024stanniocalcin1intumor pages 2-3, bai2023thestromaltumoramplifying pages 7-12, duan2024stanniocalcin1promotestemozolomide pages 8-10, xu2024integrativeanalysisof pages 12-14, choi2023microrna‑606inhibitsthe pages 11-11).
References
(wang2024stanniocalcin1intumor pages 1-2): Lele Wang, Jianjun Wang, Weijie Qiang, and Weihong Ge. Stanniocalcin-1 in tumor immunity: acts via macrophages. Frontiers in Immunology, Nov 2024. URL: https://doi.org/10.3389/fimmu.2024.1510182, doi:10.3389/fimmu.2024.1510182. This article has 4 citations and is from a peer-reviewed journal.
(wang2024stanniocalcin1intumor pages 2-3): Lele Wang, Jianjun Wang, Weijie Qiang, and Weihong Ge. Stanniocalcin-1 in tumor immunity: acts via macrophages. Frontiers in Immunology, Nov 2024. URL: https://doi.org/10.3389/fimmu.2024.1510182, doi:10.3389/fimmu.2024.1510182. This article has 4 citations and is from a peer-reviewed journal.
(wang2024stanniocalcin1intumor pages 10-10): Lele Wang, Jianjun Wang, Weijie Qiang, and Weihong Ge. Stanniocalcin-1 in tumor immunity: acts via macrophages. Frontiers in Immunology, Nov 2024. URL: https://doi.org/10.3389/fimmu.2024.1510182, doi:10.3389/fimmu.2024.1510182. This article has 4 citations and is from a peer-reviewed journal.
(bai2023thestromaltumoramplifying pages 7-12): Shuya Bai, Yuchong Zhao, Wei Chen, Wang Peng, Yun Wang, Si Xiong, Aruna, Yanling Li, Yilei Yang, Shiru Chen, Bin Cheng, and Ronghua Wang. The stromal-tumor amplifying stc1-notch1 feedforward signal promotes the stemness of hepatocellular carcinoma. Journal of Translational Medicine, Mar 2023. URL: https://doi.org/10.1186/s12967-023-04085-8, doi:10.1186/s12967-023-04085-8. This article has 19 citations and is from a peer-reviewed journal.
(duan2024stanniocalcin1promotestemozolomide pages 8-10): Chao Duan, Bincan He, Yiqi Wang, Wanying Liu, Wendai Bao, Li Yu, Jinxin Xin, Hui Gui, Junrong Lei, Zehao Yang, Jun Liu, Weiwei Tao, Jun Qin, Jie Luo, and Zhiqiang Dong. Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of mgmt. Scientific Reports, Aug 2024. URL: https://doi.org/10.1038/s41598-024-68902-w, doi:10.1038/s41598-024-68902-w. This article has 3 citations and is from a peer-reviewed journal.
(xu2024integrativeanalysisof pages 12-14): Chao Xu, ShuYuan Li, HongYuan Chen, LiangJie Chi, XiangYu Wang, Muzhen He, Qingshui Wang, Xiuli Zhang, Yao Lin, and FangQin Xue. Integrative analysis of recurrence related gene signature and stc1 in colorectal cancer proliferation and metastasis. Journal of Cancer, 15:6724-6739, Oct 2024. URL: https://doi.org/10.7150/jca.102605, doi:10.7150/jca.102605. This article has 1 citations and is from a peer-reviewed journal.
(choi2023microrna‑606inhibitsthe pages 11-11): Sujin Choi, Hyun-Ju An, H. Yeo, Min-Ji Sung, Jisu Oh, Kwanbum Lee, Seung Ah Lee, Seung Ki Kim, Junhan Kim, Isaac Kim, and Soonchul Lee. Microrna‑606 inhibits the growth and metastasis of triple‑negative breast cancer by targeting stanniocalcin 1. Oncology Reports, Nov 2023. URL: https://doi.org/10.3892/or.2023.8661, doi:10.3892/or.2023.8661. This article has 12 citations and is from a peer-reviewed journal.
id: P52823
gene_symbol: STC1
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
Stanniocalcin-1 (STC1) is a secreted homodimeric glycoprotein hormone of the stanniocalcin family,
originally characterized as a calcium-regulating hormone in fish and now known to function as a
pleiotropic autocrine/paracrine regulator in mammals. STC1 stimulates renal phosphate reabsorption
and inhibits calcium ion transport, contributing to mineral homeostasis. Recent work has identified
STC1 as a potent inhibitor (Ki = 68 pM) of the metalloproteinase PAPP-A, thereby modulating IGF
signaling through preventing cleavage of IGF-binding proteins. STC1 also functions as a selective
modulator of HGF-induced angiogenic responses and inhibits transendothelial migration of
inflammatory cells. The protein is widely expressed and is upregulated under hypoxia/stress
conditions. In the heart, STC1 inhibits L-type calcium channels and may contribute to cardiac
calcium homeostasis.
existing_annotations:
- term:
id: GO:0006874
label: intracellular calcium ion homeostasis
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation inferred from phylogenetic analysis. STC1 was originally characterized as a
calcium-regulating hormone in fish where it functions in preventing hypercalcemia [PMID:8700837].
Human STC1 has been shown to reversibly inhibit transmembrane calcium currents through L-channels
in cardiomyocytes, slowing endogenous beating rate and diminishing intracellular calcium rise
with each contraction [PMID:12663264]. The role in intracellular calcium homeostasis is well
supported by experimental evidence across the stanniocalcin family.
action: ACCEPT
reason: >-
This is a core conserved function of the stanniocalcin family. Multiple studies demonstrate
STC1's role in calcium homeostasis - it inhibits calcium uptake in fish [PMID:8700837] and
inhibits L-channel calcium currents in mammalian cardiomyocytes [PMID:12663264]. The IBA
annotation appropriately captures this evolutionarily conserved function.
supported_by:
- reference_id: PMID:8700837
supporting_text: "Recombinant hSTC inhibited the gill transport of calcium when administered to fish and stimulated renal phosphate reabsorption in the rat"
- reference_id: PMID:12663264
supporting_text: "Addition of recombinant STC1 to the medium of cultured rat cardiomyocytes slows their endogenous beating rate and diminishes the rise in intracellular calcium with each contraction"
- term:
id: GO:0005615
label: extracellular space
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for cellular component. STC1 is a secreted glycoprotein hormone, consistent
with its localization to the extracellular space. UniProt clearly indicates "Secreted" as
the subcellular location, and the protein has a signal peptide (residues 1-17) [PMID:8700837,
UniProt P52823].
action: ACCEPT
reason: >-
STC1 is well-established as a secreted hormone. The protein has a signal peptide and is
released to function in autocrine/paracrine signaling. This annotation is accurate and
represents a core aspect of STC1 biology.
supported_by:
- reference_id: PMID:8700837
supporting_text: "We have isolated a human cDNA clone encoding the mammalian homolog of stanniocalcin (STC), a calcium- and phosphate-regulating hormone that was first described in fishes where it functions in preventing hypercalcemia"
- reference_id: PMID:14500721
supporting_text: "Stanniocalcin 1 (STC1) is a secreted glycoprotein originally described as a hormone involved in calcium and phosphate homeostasis in bony fishes"
- term:
id: GO:0007165
label: signal transduction
evidence_type: IEA
original_reference_id: GO_REF:0000108
review:
summary: >-
IEA annotation based on logical inference. STC1 functions as a signaling molecule that
modulates multiple pathways including HGF/c-met signaling [PMID:14500721] and has been
shown to bind Notch1 to activate Notch signaling in cancer contexts [deep research].
However, "signal transduction" is a very broad term.
action: ACCEPT
reason: >-
While broad, this annotation is accurate. STC1 is a secreted hormone that acts via
autocrine/paracrine mechanisms to regulate cellular responses. It modulates HGF-induced
signaling and affects downstream pathways like focal adhesion kinase. As an IEA annotation,
the breadth is acceptable given the well-documented signaling roles of STC1.
supported_by:
- reference_id: PMID:14500721
supporting_text: "STC1 did not inhibit HGF-induced c-met receptor phosphorylation, but did block HGF-induced focal adhesion kinase activation"
- term:
id: GO:0005179
label: hormone activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for molecular function. STC1 is classified as a hormone in UniProt and was
originally identified as the mammalian homolog of fish stanniocalcin, a calcium-regulating
hormone. STC1 acts via autocrine/paracrine mechanisms to regulate mineral homeostasis and
cellular responses [PMID:8700837].
action: ACCEPT
reason: >-
This accurately captures STC1's function as a hormone. The stanniocalcin family was
originally characterized as hormonal regulators of mineral metabolism. STC1 is secreted
and acts on target cells to modulate calcium/phosphate handling and other cellular processes.
supported_by:
- reference_id: PMID:8700837
supporting_text: "Human stanniocalcin: a possible hormonal regulator of mineral metabolism"
- term:
id: GO:0005576
label: extracellular region
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for cellular component. This is a broader parent term of "extracellular space"
(GO:0005615) which is already annotated with IBA evidence. Both are correct - STC1 is a
secreted protein that localizes to the extracellular region.
action: ACCEPT
reason: >-
Accurate annotation. STC1 is a secreted glycoprotein and localizes to the extracellular
region. This IEA annotation is consistent with the more specific IBA annotation for
extracellular space.
supported_by:
- reference_id: PMID:8700837
supporting_text: "Human STC (hSTC) was found to be 247 amino acids long"
- term:
id: GO:0001503
label: ossification
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs. STC1 has been shown to regulate growth plate
chondrogenesis and bone development in studies using recombinant human STC1 [PMID:16377640].
The annotation is supported by evidence that STC1 overexpression causes dwarfism in mice.
action: KEEP_AS_NON_CORE
reason: >-
While STC1 does affect bone development and the annotation is accurate based on experimental
studies, ossification is not a core function of STC1. The primary functions are mineral
homeostasis, PAPP-A inhibition, and angiogenesis regulation. Bone effects may be secondary
to its role in phosphate handling and IGF signaling modulation.
supported_by:
- reference_id: PMID:16377640
supporting_text: "STC1 inhibits longitudinal bone growth directly at the growth plate"
- term:
id: GO:0005615
label: extracellular space
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs for cellular component. Duplicate of the IBA
annotation above. STC1 is clearly a secreted protein localized to the extracellular space.
action: ACCEPT
reason: >-
Accurate annotation supported by multiple lines of evidence. Having both IBA and IEA
evidence for the same term is acceptable and reflects consistent annotation across
species and methods.
supported_by:
- reference_id: PMID:14500721
supporting_text: "Stanniocalcin 1 (STC1) is a secreted glycoprotein"
- term:
id: GO:0007566
label: embryo implantation
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs. STC1 expression has been associated with
reproductive processes and decidualization, which relates to embryo implantation.
However, direct experimental evidence for STC1's role in embryo implantation is limited.
action: KEEP_AS_NON_CORE
reason: >-
This annotation may reflect expression data or ortholog-based inference rather than
direct functional evidence. STC1's pleiotropic nature means it is expressed in many
tissues including reproductive organs, but embryo implantation is not considered a
primary function based on available literature.
supported_by:
- reference_id: file:human/STC1/STC1-deep-research-falcon.md
supporting_text: "STC1 is expressed in reproductive organs"
- term:
id: GO:0016324
label: apical plasma membrane
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs. STC1 has been detected on the apical surface
of endothelial cells in vivo [PMID:17032941]. The annotation is consistent with STC1's
role in regulating transendothelial migration.
action: ACCEPT
reason: >-
Supported by direct detection of STC1 on the apical surface of endothelial cells.
This localization is relevant to STC1's function in modulating inflammatory cell
transmigration and endothelial function.
supported_by:
- reference_id: PMID:17032941
supporting_text: "STC1 regulates gene expression in cultured endothelial cells and is detected on the apical surface of endothelial cells in vivo"
- term:
id: GO:0033280
label: response to vitamin D
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs. STC1 is involved in mineral homeostasis and
vitamin D is a key regulator of calcium metabolism. The connection is plausible given
STC1's role in calcium/phosphate handling, but direct evidence from the publications
reviewed is limited.
action: KEEP_AS_NON_CORE
reason: >-
While the connection between STC1 and vitamin D signaling is biologically plausible
given their shared roles in mineral metabolism, this is not a core function based
on available direct experimental evidence. The annotation may reflect expression
regulation rather than direct functional involvement.
supported_by:
- reference_id: PMID:8700837
supporting_text: "The evidence suggests that mammalian STC, like its piscine counterpart, is a regulator of mineral homeostasis"
- term:
id: GO:0046697
label: decidualization
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs. STC1 is expressed in reproductive tissues
and may have roles in uterine biology. However, direct evidence for STC1 function in
decidualization from the primary literature reviewed is limited.
action: KEEP_AS_NON_CORE
reason: >-
This annotation likely reflects expression patterns in uterine tissue rather than
direct functional evidence. Decidualization is not a primary function of STC1 based
on the core literature, though expression in reproductive organs is documented.
supported_by:
- reference_id: file:human/STC1/STC1-deep-research-falcon.md
supporting_text: "STC1 is expressed in reproductive organs"
- term:
id: GO:0071320
label: cellular response to cAMP
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs. STC1 expression may be regulated by cAMP
signaling, but direct evidence for functional involvement in cellular response to
cAMP is limited in the literature reviewed.
action: KEEP_AS_NON_CORE
reason: >-
This annotation likely reflects transcriptional regulation of STC1 by cAMP rather
than STC1 being a mediator of cAMP responses. Not a core function based on
available evidence.
supported_by:
- reference_id: file:human/STC1/STC1-deep-research-falcon.md
supporting_text: "STC1 is induced by stress/hypoxia pathways"
- term:
id: GO:0071385
label: cellular response to glucocorticoid stimulus
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs. STC1 expression may be regulated by
glucocorticoids, but this reflects transcriptional regulation rather than STC1
being a core mediator of glucocorticoid responses.
action: KEEP_AS_NON_CORE
reason: >-
This annotation likely reflects STC1 being a glucocorticoid-responsive gene rather
than a primary mediator of glucocorticoid responses. Not a core function of STC1.
supported_by:
- reference_id: file:human/STC1/STC1-deep-research-falcon.md
supporting_text: "STC1 is widely expressed in many organs"
- term:
id: GO:0071456
label: cellular response to hypoxia
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: >-
IEA annotation transferred from orthologs. STC1 is known to be induced by hypoxia
and stress pathways. The deep research indicates STC1 is linked to hypoxia-driven
programs and functions in stress responses [deep research]. STC1 upregulation in
failing hearts is relevant to hypoxic stress [PMID:12663264].
action: ACCEPT
reason: >-
This annotation is well-supported. STC1 is induced by hypoxia/stress and may play
protective roles under hypoxic conditions. The protein is markedly upregulated in
failing hearts (a hypoxic condition) and is reduced after mechanical unloading
[PMID:12663264]. Hypoxia regulation is a documented aspect of STC1 biology.
supported_by:
- reference_id: PMID:12663264
supporting_text: "STC1 protein is markedly upregulated in cardiomyocytes and arterial walls of failing hearts pre-LVAD and is strikingly reduced after LVAD treatment"
- reference_id: file:human/STC1/STC1-deep-research-falcon.md
supporting_text: "STC1 is linked to hypoxia-driven programs and stress responses"
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: >-
IPI annotation based on high-throughput interactome study (HuRI). The study identified
STC1 interacting with MEOX2. However, "protein binding" is uninformative - it does not
specify the functional nature of the interaction.
action: MODIFY
reason: >-
"Protein binding" is too vague and uninformative. STC1 has specific and functionally
important protein interactions - most notably it binds and inhibits PAPP-A with very
high affinity (KD = 75 pM) [PMID:26195635]. It also forms homodimers. The annotation
should be replaced with more specific molecular function terms.
proposed_replacement_terms:
- id: GO:0008191
label: metalloendopeptidase inhibitor activity
additional_reference_ids:
- PMID:26195635
supported_by:
- reference_id: PMID:32296183
supporting_text: "Global insights into cellular organization and genome function require comprehensive understanding of the interactome networks"
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:26195635
review:
summary: >-
IPI annotation from PMID:26195635 which demonstrated STC1 homodimerization. The paper
states that STC1 is a "disulfide-bound homodimeric glycoprotein." UniProt also confirms
"Homodimer; disulfide-linked." IntAct records STC1-STC1 interaction.
action: ACCEPT
reason: >-
This annotation is well-supported by the primary literature. STC1 functions as a
homodimer linked by disulfide bonds. This is a core structural feature of the protein.
supported_by:
- reference_id: PMID:26195635
supporting_text: "Stanniocalcin-1 (STC1) is a disulfide-bound homodimeric glycoprotein"
- term:
id: GO:0030336
label: negative regulation of cell migration
evidence_type: IDA
original_reference_id: PMID:17032941
review:
summary: >-
IDA annotation based on direct experimental evidence. The study showed that STC1 inhibits
transmigration of macrophages and T lymphocytes through endothelial cell monolayers
[PMID:17032941]. STC1 also inhibits chemotaxis of macrophage-like cells.
action: ACCEPT
reason: >-
Well-supported by direct experimental evidence. STC1 inhibits the migration of specific
immune cell types (macrophages, T lymphocytes) across endothelial barriers. This is
a core functional role consistent with STC1's autocrine/paracrine signaling function.
supported_by:
- reference_id: PMID:17032941
supporting_text: "STC1 inhibited transmigration of macrophages and T lymphocytes through quiescent or IL-1beta-activated HUVECs but did not attenuate the transmigration of neutrophils and B lymphocytes"
- term:
id: GO:0006874
label: intracellular calcium ion homeostasis
evidence_type: IDA
original_reference_id: PMID:8700837
review:
summary: >-
IDA annotation from the foundational paper characterizing human STC1. The study showed
that recombinant hSTC inhibited calcium transport in fish gills and stimulated renal
phosphate reabsorption in rats, indicating a role in mineral metabolism and calcium
homeostasis [PMID:8700837].
action: ACCEPT
reason: >-
This is the core conserved function of stanniocalcins - regulation of calcium homeostasis.
The original identification of human STC1 demonstrated its ability to inhibit calcium
transport, consistent with fish STC function. This is fundamental to STC1 biology.
supported_by:
- reference_id: PMID:8700837
supporting_text: "Recombinant hSTC inhibited the gill transport of calcium when administered to fish and stimulated renal phosphate reabsorption in the rat"
- term:
id: GO:0051926
label: negative regulation of calcium ion transport
evidence_type: IDA
original_reference_id: PMID:8700837
review:
summary: >-
IDA annotation from the foundational paper. STC1 inhibits calcium transport - demonstrated
by recombinant hSTC inhibiting gill calcium transport in fish [PMID:8700837]. Further
supported by patch-clamp studies showing STC1 inhibits L-channel calcium currents in
cardiomyocytes [PMID:12663264].
action: ACCEPT
reason: >-
Well-supported core function. STC1 negatively regulates calcium transport across multiple
experimental systems and cell types. This is the primary molecular activity underlying
STC1's role in calcium homeostasis.
supported_by:
- reference_id: PMID:8700837
supporting_text: "Recombinant hSTC inhibited the gill transport of calcium when administered to fish and stimulated renal phosphate reabsorption in the rat"
- reference_id: PMID:12663264
supporting_text: "using whole cell patch-clamp studies in cultured rat cardiomyocytes, we find that addition of STC1 to the bath causes reversible inhibition of transmembrane calcium currents through L-channels"
- term:
id: GO:1903403
label: negative regulation of renal phosphate excretion
evidence_type: IDA
original_reference_id: PMID:8700837
review:
summary: >-
IDA annotation from the foundational paper. The study demonstrated that recombinant hSTC
"stimulated renal phosphate reabsorption in the rat" [PMID:8700837]. Stimulating
reabsorption is equivalent to negatively regulating excretion.
action: ACCEPT
reason: >-
Well-supported core function. STC1 stimulates renal phosphate reabsorption, thereby
reducing phosphate excretion. This is part of STC1's fundamental role as a regulator
of mineral homeostasis, specifically phosphate handling in the kidney.
supported_by:
- reference_id: PMID:8700837
supporting_text: "Recombinant hSTC inhibited the gill transport of calcium when administered to fish and stimulated renal phosphate reabsorption in the rat"
- term:
id: GO:0001886
label: endothelial cell morphogenesis
evidence_type: IDA
original_reference_id: PMID:14500721
review:
summary: >-
IDA annotation from the angiogenesis study. The paper showed that STC1 is "a selective
modulator of hepatocyte growth factor (HGF)-induced endothelial migration and morphogenesis"
[PMID:14500721]. STC1 acts as a "stop signal" or stabilizing factor for blood vessel
maturation.
action: ACCEPT
reason: >-
Supported by direct experimental evidence showing STC1 modulates HGF-induced endothelial
morphogenesis. This is a well-characterized function where STC1 acts to regulate the
maturation and morphogenesis of endothelial cells during angiogenesis.
supported_by:
- reference_id: PMID:14500721
supporting_text: "STC1 is a selective modulator of hepatocyte growth factor (HGF)-induced endothelial migration and morphogenesis, but not proliferation"
- term:
id: GO:0003421
label: growth plate cartilage axis specification
evidence_type: IDA
original_reference_id: PMID:16377640
review:
summary: >-
IDA annotation from the chondrogenesis study. The paper demonstrated that STC1 acts as
a "paracrine regulator of growth plate chondrogenesis" affecting growth plate
chondrocyte proliferation and differentiation [PMID:16377640].
action: KEEP_AS_NON_CORE
reason: >-
While the annotation is supported by experimental evidence, "growth plate cartilage axis
specification" is a very specific developmental term. The study primarily showed effects
on chondrocyte proliferation and differentiation, which may be secondary to STC1's
effects on phosphate transport. This is not a primary molecular function.
supported_by:
- reference_id: PMID:16377640
supporting_text: "STC1 inhibits longitudinal bone growth directly at the growth plate"
- term:
id: GO:0035988
label: chondrocyte proliferation
evidence_type: IDA
original_reference_id: PMID:16377640
review:
summary: >-
IDA annotation from the chondrogenesis study. The paper directly showed that rhSTC
"suppressed metatarsal growth, growth plate chondrocyte proliferation and
hypertrophy/differentiation" [PMID:16377640].
action: KEEP_AS_NON_CORE
reason: >-
Supported by direct experimental evidence but represents a tissue-specific effect rather
than core function. The effects on chondrocyte proliferation appear to be mediated through
phosphate transport modulation rather than direct regulation of proliferation pathways.
supported_by:
- reference_id: PMID:16377640
supporting_text: "rhSTC suppressed metatarsal growth, growth plate chondrocyte proliferation and hypertrophy/differentiation"
- term:
id: GO:0044070
label: regulation of monoatomic anion transport
evidence_type: IDA
original_reference_id: PMID:16377640
review:
summary: >-
IDA annotation from the chondrogenesis study. The paper showed that rhSTC "increased
phosphate uptake" in chondrocytes and that the effects were reversed by phosphonoformic
acid, an inhibitor of phosphate transport [PMID:16377640].
action: ACCEPT
reason: >-
Well-supported annotation consistent with STC1's core function in mineral ion transport.
The study directly demonstrated that STC1 regulates phosphate (a monoatomic anion)
transport in chondrocytes, mechanistically linking to effects on bone development.
supported_by:
- reference_id: PMID:16377640
supporting_text: "In cultured chondrocytes, rhSTC increased phosphate uptake... All these effects were reversed by culturing chondrocytes with rhSTC and phosphonoformic acid, an inhibitor of phosphate transport"
- term:
id: GO:0060348
label: bone development
evidence_type: IDA
original_reference_id: PMID:16377640
review:
summary: >-
IDA annotation from the chondrogenesis study. The paper demonstrated STC1's role in
regulating longitudinal bone growth through effects on growth plate chondrogenesis.
STC1 overexpression in mice causes dwarfism [PMID:16377640].
action: KEEP_AS_NON_CORE
reason: >-
While supported by experimental evidence, bone development effects are likely secondary
to STC1's primary role in regulating phosphate transport and possibly IGF signaling
(via PAPP-A inhibition). Not a core molecular function of STC1.
supported_by:
- reference_id: PMID:16377640
supporting_text: "STC1 inhibits longitudinal bone growth directly at the growth plate. Such growth inhibition, likely mediated by an increased chondrocyte phosphate uptake"
- term:
id: GO:0090280
label: positive regulation of calcium ion import
evidence_type: IDA
original_reference_id: PMID:17032941
review:
summary: >-
IDA annotation from PMID:17032941. However, this annotation appears inconsistent with
the major body of evidence showing STC1 INHIBITS calcium transport. The paper focuses
on endothelial function and inflammatory cell migration, and the abstract states STC1
"may involve attenuation of the intracellular calcium signal."
action: REMOVE
reason: >-
This annotation appears to be erroneous. The overwhelming evidence shows STC1 INHIBITS
calcium transport and reduces intracellular calcium levels [PMID:8700837, PMID:12663264].
PMID:17032941 actually states STC1 attenuates intracellular calcium signals in chemotaxis.
The annotation should be removed as it contradicts the established biology of STC1.
supported_by:
- reference_id: PMID:17032941
supporting_text: "The mammalian counterpart of the fish calcium-regulating hormone stanniocalcin-1 (STC1) inhibits monocyte chemotactic protein-1- and stromal-derived factor-1alpha (SDF-1alpha)-mediated chemotaxis and diminishes chemokinesis in macrophage-like RAW264.7 and U937 cells in a manner that may involve attenuation of the intracellular calcium signal"
- term:
id: GO:0005634
label: nucleus
evidence_type: IDA
original_reference_id: PMID:12663264
review:
summary: >-
IDA annotation from the cardiomyocyte study. The paper states "STC1 is diffusely expressed
in cardiomyocytes, although nuclear predominance is apparent" [PMID:12663264]. Nuclear
localization of a secreted protein is unusual but was observed in this study.
action: ACCEPT
reason: >-
Supported by direct immunolocalization studies in cardiomyocytes showing nuclear
predominance. While STC1 is primarily a secreted protein, some intracellular localization
has been documented, possibly related to internalization mechanisms.
supported_by:
- reference_id: PMID:12663264
supporting_text: "STC1 is diffusely expressed in cardiomyocytes, although nuclear predominance is apparent"
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:12663264
review:
summary: >-
IDA annotation from the cardiomyocyte study. The paper states "STC1 is diffusely expressed
in cardiomyocytes" indicating cytoplasmic localization [PMID:12663264]. As a secreted
protein, STC1 transits through the cytoplasm during biosynthesis.
action: ACCEPT
reason: >-
Supported by immunolocalization studies. STC1 was detected diffusely in cardiomyocytes,
consistent with cytoplasmic presence during secretory pathway transit or after
internalization.
supported_by:
- reference_id: PMID:12663264
supporting_text: "STC1 is diffusely expressed in cardiomyocytes"
- term:
id: GO:0006874
label: intracellular calcium ion homeostasis
evidence_type: IDA
original_reference_id: PMID:12663264
review:
summary: >-
IDA annotation from the cardiomyocyte study. The paper directly demonstrated that STC1
affects intracellular calcium in cardiomyocytes by inhibiting L-channel calcium currents
and reducing intracellular calcium rise with each contraction [PMID:12663264].
action: ACCEPT
reason: >-
Strong experimental evidence showing STC1 regulates intracellular calcium homeostasis
in cardiomyocytes. This complements the IBA and earlier IDA annotations for the same
term and represents a core function of STC1.
supported_by:
- reference_id: PMID:12663264
supporting_text: "Addition of recombinant STC1 to the medium of cultured rat cardiomyocytes slows their endogenous beating rate and diminishes the rise in intracellular calcium with each contraction"
- term:
id: GO:0010596
label: negative regulation of endothelial cell migration
evidence_type: IDA
original_reference_id: PMID:14500721
review:
summary: >-
IDA annotation from the angiogenesis study. The paper showed that "STC1 is a selective
modulator of hepatocyte growth factor (HGF)-induced endothelial migration" - specifically
it inhibits HGF-induced migration [PMID:14500721].
action: ACCEPT
reason: >-
Well-supported by direct experimental evidence. STC1 selectively inhibits HGF-induced
endothelial cell migration (but not VEGF or bFGF-induced migration). This is a key
function in STC1's role as an autocrine modulator of angiogenesis.
supported_by:
- reference_id: PMID:14500721
supporting_text: "STC1 is a selective modulator of hepatocyte growth factor (HGF)-induced endothelial migration and morphogenesis, but not proliferation. STC1 did not inhibit proliferative or migratory responses to vascular endothelial growth factor or basic fibroblast growth factor."
- term:
id: GO:0086004
label: regulation of cardiac muscle cell contraction
evidence_type: IDA
original_reference_id: PMID:12663264
review:
summary: >-
IDA annotation from the cardiomyocyte study. The paper demonstrated that STC1 "slows
their endogenous beating rate" in cultured cardiomyocytes through L-channel inhibition
[PMID:12663264].
action: ACCEPT
reason: >-
Supported by direct functional evidence showing STC1 regulates cardiomyocyte
contractility by inhibiting calcium currents and slowing beating rate. This may
be relevant to cardiac pathophysiology in heart failure.
supported_by:
- reference_id: PMID:12663264
supporting_text: "Addition of recombinant STC1 to the medium of cultured rat cardiomyocytes slows their endogenous beating rate"
# Adding missing key annotation for PAPP-A inhibition
- term:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
evidence_type: IDA
original_reference_id: PMID:26195635
review:
summary: >-
New annotation based on PMID:26195635 which demonstrated that STC1 is a potent inhibitor
of the metalloproteinase PAPP-A. STC1 binds PAPP-A with very high affinity (KD = 75 pM)
and inhibits its proteolytic activity (Ki = 68 pM). This inhibition affects IGF signaling
by preventing IGFBP cleavage.
action: NEW
reason: >-
This represents a newly recognized and important molecular function of STC1 that should
be annotated. STC1 is a proteinase inhibitor specific for the pappalysin family of
metalloproteinases. This function links STC1 to IGF signaling regulation and may
explain some of its growth-related effects.
supported_by:
- reference_id: PMID:26195635
supporting_text: "We here demonstrate that STC1 is an inhibitor of the metzincin metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A)... STC1 potently (Ki = 68 pm) inhibits PAPP-A cleavage of IGFBP-4"
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings:
- statement: STC1 role in calcium homeostasis is evolutionarily conserved across the stanniocalcin family
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.
findings:
- statement: Multiple annotations transferred from orthologous genes based on evolutionary conservation
- id: GO_REF:0000108
title: Automatic assignment of GO terms using logical inference, based on inter-ontology links.
findings:
- statement: Signal transduction annotation inferred from hormone activity
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods.
findings:
- statement: Hormone activity and extracellular localization annotations from automated methods
- id: PMID:12663264
title: 'Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure.'
findings:
- statement: STC1 is upregulated in failing hearts and reduced after mechanical unloading
- statement: STC1 inhibits L-type calcium channels in cardiomyocytes
- statement: STC1 slows cardiomyocyte beating rate and reduces intracellular calcium transients
- statement: STC1 shows diffuse cytoplasmic expression with nuclear predominance in cardiomyocytes
- id: PMID:14500721
title: Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor.
findings:
- statement: STC1 selectively inhibits HGF-induced endothelial migration and morphogenesis
- statement: STC1 does not affect VEGF or bFGF-induced responses
- statement: STC1 blocks HGF-induced focal adhesion kinase activation
- statement: STC1 may serve as a stop signal for blood vessel maturation
- id: PMID:16377640
title: Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis.
findings:
- statement: STC1 inhibits longitudinal bone growth at the growth plate
- statement: STC1 increases phosphate uptake in chondrocytes
- statement: Effects on growth are mediated through phosphate transport
- statement: STC1 suppresses chondrocyte proliferation and differentiation
- id: PMID:17032941
title: Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes.
findings:
- statement: STC1 inhibits transmigration of macrophages and T lymphocytes
- statement: STC1 does not affect neutrophil or B lymphocyte migration
- statement: STC1 is detected on apical surface of endothelial cells in vivo
- statement: STC1 may attenuate intracellular calcium signaling
- id: PMID:26195635
title: Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A.
findings:
- statement: STC1 is a potent inhibitor of PAPP-A (Ki = 68 pM)
- statement: STC1 binds PAPP-A with high affinity (KD = 75 pM)
- statement: STC1 forms homodimers via disulfide bonds
- statement: STC1 antagonizes PAPP-A-mediated IGF receptor phosphorylation
- statement: STC1 and STC2 are proteinase inhibitors specific for pappalysins
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings:
- statement: High-throughput Y2H screening identified STC1 protein interactions
- statement: Part of the HuRI comprehensive human interactome project
- id: PMID:8700837
title: 'Human stanniocalcin: a possible hormonal regulator of mineral metabolism.'
findings:
- statement: First characterization of human STC1
- statement: STC1 inhibits calcium transport in fish gills
- statement: STC1 stimulates renal phosphate reabsorption in rats
- statement: STC1 localizes to nephron tubules in kidney
- id: file:human/STC1/STC1-deep-research-falcon.md
title: Deep research report on STC1
findings:
- statement: STC1 is a secreted dimeric glycoprotein functioning via autocrine/paracrine mechanisms
- statement: STC1 is upregulated by hypoxia and stress pathways
- statement: STC1 directly binds Notch1 in cancer contexts
- statement: STC1 acts as a phagocytosis checkpoint through macrophage-centered effects
- statement: High STC1 expression associated with poor cancer prognosis
core_functions:
- molecular_function:
id: GO:0005179
label: hormone activity
description: >-
STC1 is a secreted glycoprotein hormone that acts via autocrine/paracrine mechanisms
to regulate mineral homeostasis and cellular responses in target tissues.
supported_by:
- reference_id: PMID:8700837
supporting_text: "Human stanniocalcin: a possible hormonal regulator of mineral metabolism"
- molecular_function:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
description: >-
Recently discovered function - STC1 potently inhibits PAPP-A metalloproteinase with
Ki = 68 pM, thereby modulating IGF signaling by preventing IGFBP-4 cleavage.
supported_by:
- reference_id: PMID:26195635
supporting_text: "STC1 potently (Ki = 68 pm) inhibits PAPP-A cleavage of IGFBP-4"
- molecular_function:
id: GO:0042802
label: identical protein binding
description: >-
STC1 functions as a disulfide-linked homodimer, which is essential for its biological
activity as a secreted hormone.
supported_by:
- reference_id: PMID:26195635
supporting_text: "Stanniocalcin-1 (STC1) is a disulfide-bound homodimeric glycoprotein"
directly_involved_in:
- id: GO:0006874
label: intracellular calcium ion homeostasis
- id: GO:0051926
label: negative regulation of calcium ion transport
- id: GO:1903403
label: negative regulation of renal phosphate excretion
locations:
- id: GO:0005576
label: extracellular region
proposed_new_terms:
- proposed_name: pappalysin inhibitor activity
proposed_definition: >-
Inhibition of the proteolytic activity of pappalysin family metalloproteinases (PAPP-A
and PAPP-A2). Stanniocalcins (STC1 and STC2) specifically inhibit these enzymes but
not other metalloproteinases or serine proteinases.
justification: >-
STC1 and STC2 specifically inhibit the pappalysin family of metalloproteinases
(PAPP-A and PAPP-A2) but not other metalloproteinases or serine proteinases
[PMID:26195635]. A more specific term would be valuable for precise annotation.
proposed_parent:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
supported_by:
- reference_id: PMID:26195635
supporting_text: "We therefore conclude that the STCs are proteinase inhibitors, probably restricted in specificity to the pappalysin family of metzincin metalloproteinases"
suggested_questions:
- question: >-
What is the receptor for STC1 in mammalian tissues beyond Notch1? While Notch1 has been
identified as a receptor in cancer contexts, the broader receptor landscape for STC1
remains incompletely defined. Understanding the receptor(s) would clarify the signaling mechanism.
- question: >-
Does the PAPP-A inhibitory function of STC1 contribute to its effects on bone growth?
STC1 overexpression causes dwarfism, and STC1 inhibits PAPP-A which regulates IGF signaling.
It is unclear if growth effects are primarily through phosphate transport or IGF axis modulation.
suggested_experiments:
- description: >-
Test whether STC1 effects on chondrocyte proliferation are blocked by PAPP-A
overexpression to determine if PAPP-A inhibition contributes to growth plate effects.
If PAPP-A inhibition is the mechanism, excess PAPP-A should rescue STC1-mediated
growth suppression.
hypothesis: >-
PAPP-A inhibition contributes to STC1-mediated growth suppression in chondrocytes
- description: >-
Identify the primary receptor for STC1 in endothelial cells using crosslinking
and mass spectrometry approaches to identify endothelial cell surface receptor(s)
mediating STC1 effects on HGF signaling and migration.
hypothesis: >-
STC1 has a specific cell surface receptor in endothelial cells distinct from Notch1